These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8362887)

  • 21. The impact of reimbursement changes for intracoronary stents on providers and Medicare.
    Vaitkus PT
    Am J Manag Care; 1998 Aug; 4(8):1097-102. PubMed ID: 10182885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicaid program and State Children's Health Insurance Program (SCHIP) payment error rate measurement. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(166):51049-85. PubMed ID: 16941786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
    LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
    Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Payment of hospital cardiac services.
    Unger WJ
    Hosp Technol Ser; 1991; 10(26):1-148. PubMed ID: 10115896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing high cost and biotech drugs: two institutions' perspectives.
    Dana WJ; McWhinney B
    Hosp Formul; 1994 Sep; 29(9):638-45. PubMed ID: 10137060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The insurance refund request: a legal analysis.
    Rollman SO
    Healthc Financ Manage; 1998 Dec; 52(12):52-4. PubMed ID: 10338798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicare program: changes to the hospital outpatient prospective payment system and CY 2008 payment rates, the ambulatory surgical center payment system and CY 2008 payment rates, the hospital inpatient prospective payment system and FY 2008 payment rates; and payments for graduate medical education for affiliated teaching hospitals in certain emergency situations Medicare and Medicaid programs: hospital conditions of participation; necessary provider designations of critical access hospitals. Interim and final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Nov; 72(227):66579-7226. PubMed ID: 18044033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slow pay and claims denials: welcome to the world of managed care.
    Hosp Case Manag; 1998 Jun; 6(6):109-12. PubMed ID: 10180317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are urologists fairly reimbursed for complex procedures: failure of 22 modifier?
    Lotan Y; Bagrodia A; Roehrborn CG; Scott J
    Urology; 2008 Sep; 72(3):494-7. PubMed ID: 18597834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple steps to reimbursement success.
    Piascik P
    Am Pharm; 1995 Aug; NS35(8):9-10. PubMed ID: 7677059
    [No Abstract]   [Full Text] [Related]  

  • 31. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 3: payment.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Nov; 3(11):842-50. PubMed ID: 17412183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopharmaceutical payment and coverage: are cost control policies too restrictive? Industrial Biotechnology Association.
    Healthspan; 1990 Jun; 7(6):6-9. PubMed ID: 10105178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 2: coverage.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Oct; 3(10):772-7. PubMed ID: 17412167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicaid and indigent care issue brief: Medicaid: provider reimbursement: year end report-2003.
    Johnson P
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-25. PubMed ID: 14969256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review this, insurers. Maryland hospitals say needed care is being denied.
    Morrissey J
    Mod Healthc; 1998 Apr; 28(17):20-1. PubMed ID: 10179156
    [No Abstract]   [Full Text] [Related]  

  • 37. Reimbursement for outpatient biotech drugs, Part 1.
    Dasher T
    Am Pharm; 1993 Jul; NS33(7):16-7. PubMed ID: 8342488
    [No Abstract]   [Full Text] [Related]  

  • 38. HFMA forums toolbox. Medicare checklists for assessing reimbursement under MS-DRGs.
    Thompson D; Wolters T
    Healthc Financ Manage; 2008 Nov; 62(11):125-6. PubMed ID: 18990846
    [No Abstract]   [Full Text] [Related]  

  • 39. Coordination of benefits.
    Anderson LS
    Issue Brief Cent Medicare Educ; 2003; 4(10):1-6. PubMed ID: 14992217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defense for physicians under attack.
    Gilchrist AG
    Pa Med; 1989 Jul; 92(7):28-30. PubMed ID: 2666913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.